SCHEMBL5698674

SCHEMBL5698674

C=CC=CC(=O)NN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18019256 1.00
SCHEMBL28403238 0.90 ALDH1A1 (0.32)
SCHEMBL11816978 0.83 MAOB (0.39)
SCHEMBL11051266 0.83 MAOB (0.39)
Maleic Hydrazide SCHEMBL10745257 0.79 ALDH1A1 (0.42)
Maleic Hydrazide SCHEMBL55070 0.76 CYP1A2 (0.44)
Maleic Hydrazide SCHEMBL28265377 0.76 CYP1A2 (0.44)
Maleic Hydrazide SCHEMBL466482 0.76 CYP1A2 (0.44)
Maleic Hydrazide SCHEMBL1534936 0.76 CYP1A2 (0.44)
SCHEMBL28355055 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1682143-A2 COMBINATIONS COMPRISING AN HSP90 INHIBITOR AND A PHOPHODIESTERASE INHIBITOR FOR TREATING OR PREVENTING NEOPLASIA Pharmacia Corporation (US) 2006-07-26 EP disclosed
WO-2005044194-A2 TREATMENT OR PREVENTION OF NEOPLASIA BY USE OF AN Hsp90 INHIBITOR PHARMACIA CORPORATION (US) 2005-05-19 WO disclosed
WO-2005041879-A2 COMBINATIONS COMPRISING AN Hsp90 INHIBITOR AND A PHOPHODIESTERASE INHIBITOR FOR TREATING OR PREVENTING NEOPLASIA PHARMACIA CORPORATION (US) 2005-05-12 WO disclosed